Outlook Therapeutics, Inc. has announced the commencement of an underwritten public offering of its common stock and accompanying warrants to raise capital for working and corporate purposes. The ...
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) , a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results